Document Detail

Clustering of Metabolic Abnormalities Among Obese Patients and Mortality After Percutaneous Coronary Intervention.
MedLine Citation:
PMID:  21420054     Owner:  NLM     Status:  Publisher    
Although current literature demonstrates metabolic abnormalities are associated with mortality, obese patients who tend to have more metabolic abnormalities paradoxically have lower overall mortality rates compared to their normal-weight counterparts. In this study, we examined the prevalence of metabolic abnormality clustering and its relation to mortality in obese and normal-weight patients after percutaneous coronary intervention (PCI). Patients (n = 9,673) undergoing elective PCI from October 2003 through December 2006 at a single urban hospital were categorized by body mass index (BMI) levels of 18.5 to 24.9, 25.0 to 29.9, 30.0 to 34.9, and ≥35 kg/m(2) and by number of metabolic abnormalities possessed (hypertension, impaired fasting glucose/diabetes, triglycerides ≥150 mg/dl, high-density lipoprotein cholesterol < 40 mg/dl, and C-reactive protein ≥2.0 mg/L). All-cause mortality was assessed through June 30, 2007. Mean age of patients was 65.9 years and 66% were men. Prevalences of 4 or 5 metabolic abnormalities were 12%, 18%, 24%, and 31% in patients with BMI levels of 18.5 to 24.9, 25.0 to 29.9, 30 to 34.9, and ≥35 kg/m(2), respectively. In patients with BMI of 30.0 to 34.9 kg/m(2), hazard ratios (95% confidence intervals) for mortality associated with 2, 3, and 4 to 5 metabolic abnormalities versus 0 to 1 metabolic abnormality were 1.31 (0.79 to 2.17), 1.42 (0.83 to 2.43), and 2.39 (1.24 to 4.59), respectively. Analogous hazard ratios for patients with BMI ≥35 kg/m(2) were 1.94 (0.90 to 4.20), 1.44 (0.63 to 3.28), and 2.17 (0.91 to 5.18). All-cause mortality rates per 1,000 person-years were 55.5, 33.7, 28.3, and 33.8 in patients with BMI levels of 18.5 to 24.9, 25 to 29.9, 30 to 34.9, and ≥35 kg/m(2), respectively. In conclusion, BMI levels of 25.0 to 29.9 and 30 to 34.9 kg/m(2) were associated with lower all-cause mortality after PCI. However, an increased number of metabolic abnormalities translated into increased all-cause mortality.
Sameer Bashey; Paul Muntner; Annapoorna S Kini; Ricardo Esquitin; Louai Razzouk; Shiny Mathewkutty; Rachel P Wildman; April P Carson; Michael C Kim; Pedro R Moreno; Samin K Sharma; Michael E Farkouh
Related Documents :
10856324 - Anaemia in lung transplant patient caused by parvovirus b19.
7277644 - Value of glycosylated hemoglobin measurements after acute myocardial infarction.
15307104 - Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglob...
18473244 - An estimation of the incidence and demographic picture of the major hemoglobinopathies ...
19811264 - Retinoid x receptor beta polymorphisms do not explain functional differences in vitamin...
22922574 - Fcγ receptor polymorphisms do not predict response to intravenous immunoglobulin in my...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-17
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
The Mount Sinai Cardiovascular Institute, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patien...
Next Document:  Effect of Clinical Triggers on Positive Responses to Tilt-Table Testing Potentiated With Nitroglycer...